Anzeige
Mehr »
Login
Donnerstag, 17.10.2024 Börsentäglich über 12.000 News von 676 internationalen Medien
5 Millionen Unzen und steigend: NexGold Mining's unerschlossene Goldstraße
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
243 Leser
Artikel bewerten:
(1)

Sanwire Corporation Announces Third Quarter 2022 Record-Breaking Revenues, Provides Shareholder Update

SAN FRANCISCO, CA / ACCESSWIRE / November 22, 2022 / Sanwire Corporation ("Sanwire" or the "Company") (OTC PINK:SNWR), an entertainment technology innovator, and its wholly owned subsidiary, Intercept Music Inc ("Intercept") - a multi-faceted label and artist-centric platform solution provider, are pleased to announce third quarter 2022 financial performance results.

Third quarter 2022 was another record-breaking quarter for the Company, with revenues up 250% over second quarter 2022, and up 350% over third quarter 2021. Three main factors continue to drive revenues - our "everything" dashboard, our growing list of marketing services, and 100% data transparency.

The business model is solidifying. Labels continue to be our best source of artists. Since they bring their artist management and understanding of the business side, and they are able to oversee the artist involvement and the music marketing. We make the least margin on distribution, but the music drives demand for the marketing services, which are the highest margin and represent much more gross profit for us.

Until recently, marketing services were only available to our customers for music we distributed. In late September 2022, we began offering marketing services to outside artists and labels. Our internal customers receive a 20% discount if they are distributing their music through us. This has led to an increase in marketing service sales, which created another pathway to gain the trust of the artist that can lead to future distribution. As a result, we now have a full-time person identifying and vetting these services, and then prepare them for our reps to take to market. In January 2022 we had five marketing services to sell. Today we have 22 services, with 13 more in the queue. The average spend per new music release continues to rise.

We have many labels which have built their entire service offering around our platform. We see labels adding artists and buying marketing services on autopilot now. We've seen increases in the merchandise sales by artist. Our average artist, in terms of streams, marketing expenditures, and overall quality of music, has risen. Nine months ago, our largest artists had 700,000 monthly Spotify listeners. Today our largest has 25 million. Larger artists tend to spend more on marketing too.

We see positive responses from sophisticated labels, which has been reflected in some key partnerships. One of the recent ones was the Sapphire group of labels. Across Sapphire's four labels, they will bring their 120 artists over to our platform for distribution and marketing services, they intend to add another 100 artists over the next year, and they just added eight new marketing services for us to introduce to our existing artists and labels including mixing and sync licensing for movies, radio and television.

In September 2022, we expanded into the Latin market. Our website and software are now available in Spanish and Portuguese. We have multilingual staff who are trained and able to support every department, from customer sales, support, onboarding, marketing services and distribution. So far, we have 12 Latin marketing services available, including some not available in the U.S. Our new Latin sales team has signed one major Latin Artist (Marcos Menchaca - 1.2 million Spotify listeners), closed a label with 12 artists in Guadalajara and Mexico City, and an artist from Peru.

During fourth quarter 2022, we will continue to expand in the Latin markets. We also expect to announce several major global partnerships that will drive US sales in 2023. We will launch more marketing services, and we hope to add more music catalogs.

With several successive quarters of growth, the Company will be finalizing its funding and capital requirements for the medium term and should be done by the end of the fourth quarter 2022. We believe that with the explosion of music being created, the success of digital promotion, and the merger activities taking place within the music industry, the time is right now.

"I'd like to personally thank our shareholders; we could not have achieved these results without your support," said Tod Turner, Intercept's president. "We've laid out a strong growth foundation and an incredible team to execute."

"Intercept Music is proving to be an international force within the music industry," proudly stated Ron Hughes, CEO of Sanwire Corporation.

About Intercept Music Inc.
Intercept Music champions creative musicians. The entertainment technology company harnesses the power of premium distribution, sizzling social media, meaningful marketing, monumental merchandising, and customizable promotional services to empower independent labels and their artists to build audiences and drive revenue. The Software as a Service (SaaS) company focuses exclusively on the independent music market, the fastest-growing sector of the music industry. Learn more at interceptmusic.com or visit Intercept Music's Instagram, Twitter, and Facebook.

About Sanwire Corporation
Sanwire Corporation (OTC:SNWR), a diversified company with a focus on technologies for the entertainment industry, has been involved in aggregating technologies for several years. We look for opportunities in fragmented markets, where technology can be applied to consolidate services into a single platform of delivery. Our current focus is advanced entertainment technologies. For more information, visit sanwirecorporation.com.

For press and corporate inquiries, please contact:
Ronald E. Hughes
CEO, Sanwire Corporation
ron.hughes.management@gmail.com
ir@sanwirecorporation.com, or press@interceptmusic.com

Safe Harbor Statement
This release contains forward-looking statements. All statements regarding our expected future financial positions, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the OTC Markets, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties, and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE: Sanwire Corporation

View source version on accesswire.com:
https://www.accesswire.com/727669/Sanwire-Corporation-Announces-Third-Quarter-2022-Record-Breaking-Revenues-Provides-Shareholder-Update

© 2022 ACCESSWIRE
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.